Elsevier

Kidney International Reports

Volume 5, Issue 9, September 2020, Pages 1387-1402
Kidney International Reports

Review
CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and Management

https://doi.org/10.1016/j.ekir.2020.04.027Get rights and content
Under a Creative Commons license
open access

Chronic kidney disease–associated pruritus (CKD-aP) is a common, troubling and in some cases debilitating problem for patients with CKD and end-stage renal disease. Despite a prevalence rate of approximately 20% in CKD and 40% in end-stage renal disease, and a clear association with poorer psychosocial and medical outcomes, this condition is often underreported by patients and overlooked by health care providers. This is likely due, in part, to uncertainty regarding its pathogenesis and treatment. Most commonly, CKD-aP is attributed to toxin build-up, peripheral neuropathy, immune system dysregulation, or opioid dysregulation. Prior treatment studies of CKD-aP have targeted these potential etiologies but have been limited by noncontrolled design, small sample size, and non-uniform definitions of CKD-aP. Recently, several large, randomized controlled trials targeting opioid dysregulation have yielded promising results. These trials have spurred new hope for understanding and treating this condition.

Keywords

chronic kidney disease
depression
end-stage renal disease
itching
pruritus
uremia

Cited by (0)